New hope for tough leukemia: daily drug trial opens
NCT ID NCT05211570
First seen Nov 01, 2025 · Last updated May 12, 2026 · Updated 26 times
Summary
This study tests a daily intravenous drug called AB8939 in adults with acute myeloid leukemia (AML) that has returned or not responded to prior treatments. The main goal is to find a safe dose and see if the drug can shrink or control the cancer. About 78 participants will take part in this early-phase trial.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUTE MYELOID LEUKEMIA REFRACTORY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Clínica Universidad de Navarra
RECRUITINGPamplona, Spain
-
General University Hospital of Alicantet (Hospital General Universitario Dr. Balmis de Alicante)
RECRUITINGAlicante, Spain
-
Hospital San Pedro de Alcantara
RECRUITINGCáceres, Spain
-
Hospital Universitario 12 de Octubre
RECRUITINGMadrid, Spain
-
Hospital Universitario Quirónsalud
RECRUITINGMadrid, Spain
-
Institut Paoli Calmettes
NOT_YET_RECRUITINGMarseille, France
-
MD Anderson Cancer Center
NOT_YET_RECRUITINGHouston, Texas, 77030, United States
-
MD Anderson Cancer Center Madrid
RECRUITINGMadrid, Spain
-
National and Kapodistrian University of Athens NKUA · Department of Hematology and Bone marrow Transplantation Unit
RECRUITINGAthens, Greece
-
Virgen del Rocío University Hospital (Hospital Universitario Virgen del Rocío)
RECRUITINGSeville, Spain
Conditions
Explore the condition pages connected to this study.